Age, the presence of comorbidities, biological DMARD (bDMARD) use, and baseline DAS-28 CRP scores were found to be significantly effective variables in the univariate regression analysis in which the factors affecting the presence of polypharmacy at the baseline were evaluated for patients in the RA group. Here, CRP is linked to rheumatoid arthritis.